In vitro and in vivo studies on stilbene analogs as potential treatment agents for colon cancer

Shiby Paul, Cassia S. Mizuno, Hong Jin Lee, Xi Zheng, Sarah Chajkowisk, John M. Rimoldi, Allan Conney, Nanjoo Suh, Agnes M. Rimando

Research output: Contribution to journalArticlepeer-review

41 Scopus citations

Abstract

Based on the potential of resveratrol as a colon cancer chemopreventive agent, a set of 26 stilbenes were synthesized and tested against the colon cancer cell lines HT-29 and Caco-2. (Z)-4-(3,5-Dimethoxystyryl)aniline (4), (Z)-methyl-4-(3,5-dimethoxystyryl)benzoate (6), and (Z)-1,3-dimethoxy-5-(4- methoxystyryl)benzene (10) showed strong inhibitory activity in vitro. In vivo studies using HT-29 xenografts in immunodeficient mice were conducted with 4, 6 and 10, together with their corresponding trans isomers (3, 5, and 9, respectively), at the dose of 10 mg/kg body weight. Tumor volume was significantly lowered in 3-, 4-, and 9-treated groups. The cis- and trans-amino analogs (4 and 3, respectively) had similar effect on tumor growth, a 40% decrease compared to the control. Analysis of the serum revealed that 4 isomerized to 3, which may explain their similar effects in SCID mice. Stilbenes 5, 6, 9, and 10 retained their configurations in the serum. Stilbenes 6 and 10 lacked tumor-suppressive effect in SCID mice; the serum levels of these analogs were low (18.8 and 15.5 ng/mL, respectively). Stilbene 9, while weakly active in vitro demonstrated good activity in vivo, was found at higher levels in the serum (69.9 ng/mL) compared to 10. The anti-tumorigenic activity of these stilbene analogs may be partly linked to their effects on proteins involved in cell proliferation, as observed by lowered expression of proliferating cell nuclear antigen and upregulation of the cyclin-dependent kinase inhibitor, p27, in the tumor tissues. Overall, identification of the anti-tumorigenic potential of these compounds provides opportunities for their use against colorectal cancer. Twenty-seven stilbene analogs were tested, and the cis isomers were inhibitorier than the trans isomers against colon cancer cells in vitro. The cis-amino analog isomerized to the trans-amino analog in vivo and suppressed tumor growth in SCID mice the most.

Original languageEnglish (US)
Pages (from-to)3702-3708
Number of pages7
JournalEuropean Journal of Medicinal Chemistry
Volume45
Issue number9
DOIs
StatePublished - Sep 2010

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Drug Discovery
  • Organic Chemistry

Keywords

  • 4-(3,5-Dimethoxystyryl)aniline
  • Colon cancer
  • HT-29 xenograft
  • Stilbenes

Fingerprint Dive into the research topics of 'In vitro and in vivo studies on stilbene analogs as potential treatment agents for colon cancer'. Together they form a unique fingerprint.

Cite this